PTH 1-34 promoted bone formation by regulating iron metabolism in unloading-induced bone loss

PTH 1-34 (teriparatide) is approved by FDA for the treatment of postmenopausal osteoporosis. Iron overload is a major contributing factor for bone loss induced by unloading. Whether iron metabolism is involved in the regulation of PTH 1-34 on unloading-induced osteoporosis has not yet been reported....

Descripción completa

Detalles Bibliográficos
Autores principales: Che, Jingmin, Ren, Weihao, Chen, Xin, Wang, Fang, Zhang, Gejing, Shang, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933505/
https://www.ncbi.nlm.nih.gov/pubmed/36818465
http://dx.doi.org/10.3389/fendo.2022.1048818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933505/
https://www.ncbi.nlm.nih.gov/pubmed/36818465
http://dx.doi.org/10.3389/fendo.2022.1048818

Ejemplares similares